Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H23N5O2S.CH4O3S |
| Molecular Weight | 553.653 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CN1C=C(C2=C1C=CC=C2)C3=C(C(=O)NC3=O)C4=CN(CCCSC(N)=N)C5=C4C=CC=C5
InChI
InChIKey=SAWVGDJBSPLRRB-UHFFFAOYSA-N
InChI=1S/C25H23N5O2S.CH4O3S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20;1-5(2,3)4/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32);1H3,(H,2,3,4)
| Molecular Formula | C25H23N5O2S |
| Molecular Weight | 457.547 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | CH4O3S |
| Molecular Weight | 96.106 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21943284 | https://www.ncbi.nlm.nih.gov/pubmed/10998351 | https://www.ncbi.nlm.nih.gov/pubmed/16302800 |
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/21943284 | https://www.ncbi.nlm.nih.gov/pubmed/10998351 | https://www.ncbi.nlm.nih.gov/pubmed/16302800 |
RO-31-8220 is a cell-permeable staurosporine analog, that shows potent inhibition of PKC α, PKC βI, PKC βII, PKC γ, and PKC ε. Ro 31-8220 also inhibits MSK1, MAPKAPK1, RSK, GSK3β, and S6K1 with a potency similar to that for PKC. Ro 31-8220 alters cellular protein kinase C localization and potently inhibits the growth of A549 and MCF-7 cells with IC50 of 0.78 μM and 0.897 μM, respectively. RO 31-8220 enhances epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation. Ro 31-8220 significantly decreases apoE secretion from primary human macrophages by inhibiting vesicular transport of apoE to the plasma membrane without significantly affecting apoE mRNA or apoE protein levels.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL262 |
2.8 nM [IC50] | ||
Target ID: CHEMBL2147 |
8.0 nM [Kd] | ||
Target ID: CHEMBL2345 |
10.0 nM [IC50] | ||
Target ID: CHEMBL4501 |
15.0 nM [IC50] | ||
Target ID: CHEMBL4237 |
8.0 nM [IC50] | ||
Target ID: CHEMBL299 |
15.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathway. | 2015-09-21 |
|
| MAPK- and PKC/CREB-dependent induction of interleukin-11 by the environmental contaminant formaldehyde in human bronchial epithelial cells. | 2012-02-06 |
|
| Molecular investigation of the effects of lindane in rat hepatocytes: microarray and mechanistic studies. | 2011-12 |
|
| All-trans retinoic acid and a novel synthetic retinoid tamibarotene (Am80) differentially regulate CD38 expression in human leukemia HL-60 cells: possible involvement of protein kinase C-delta. | 2011-08 |
|
| SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration. | 2011-05-26 |
|
| Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling. | 2009-11-15 |
|
| Mechanism of action of the stimulatory effect of apigenin-6-C-(2''-O-alpha-l-rhamnopyranosyl)-beta-L-fucopyranoside on 14C-glucose uptake. | 2009-05-15 |
|
| A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate. | 2009-03 |
|
| Differential roles of MAPKs and MSK1 signalling pathways in the regulation of c-Jun during phenylephrine-induced cardiac myocyte hypertrophy. | 2009-02 |
|
| PKC promotes proliferation of airway smooth muscle cells by regulating cyclinD1 expression in asthmatic rats. | 2008-06 |
|
| Heme oxygenase-1 mediates the anti-inflammatory effect of Curcumin within LPS-stimulated human monocytes. | 2008-06 |
|
| Differential effects of tumor necrosis factor-alpha and interleukin-1beta on cell death in human articular chondrocytes. | 2008-06 |
|
| Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells. | 2008-04 |
|
| Progress in allergy signal research on mast cells: up-regulation of histamine signal-related gene expression in allergy model rats. | 2008-03 |
|
| Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. | 2008-03 |
|
| A genomic screen for activators of the antioxidant response element. | 2007-03-20 |
|
| Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin. | 2007-02-01 |
|
| Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. | 2006-09-15 |
|
| Roles of protein kinase C, Ca2+, Pyk2, and c-Src in agonist activation of rat lacrimal gland p42/p44 MAPK. | 2006-08 |
|
| P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1. | 2006-08 |
|
| Zinc is required for Fc epsilon RI-mediated mast cell activation. | 2006-07-15 |
|
| Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. | 2006-07-01 |
|
| Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. | 2006-02 |
|
| Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. | 2005-08 |
|
| Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. | 2004-11 |
|
| Inhibition of human immunodeficiency virus type 1 replication by Z-100, an immunomodulator extracted from human-type tubercle bacilli, in macrophages. | 2004-09 |
|
| Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. | 2004-02-01 |
|
| Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. | 2003-11-14 |
|
| Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. | 2003-10 |
|
| Distinct protein kinase C isoforms mediate regulation of vascular endothelial growth factor expression by A2A adenosine receptor activation and phorbol esters in pheochromocytoma PC12 cells. | 2003-04-25 |
|
| Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. | 2003-03-15 |
|
| Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein. | 2002-11-15 |
|
| Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. | 2002-07-15 |
|
| Regulation of cyclooxygenase-2 expression by phospholipase D in human amnion-derived WISH cells. | 2002-03 |
|
| Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway. | 2002-01 |
|
| Regulation of SP-B and SP-C secretion in rat type II cells in primary culture. | 2001-12 |
|
| Phosphorylation is involved in the activation of metal-regulatory transcription factor 1 in response to metal ions. | 2001-11-09 |
|
| Gene expression profile in BALB/c-3T3 cells transformed with beryllium sulfate. | 2001-09 |
|
| Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species. | 2001-06 |
|
| ERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cells. | 2000-03 |
|
| Protein phosphatase-protein kinase interplay modulates alpha 1b-adrenoceptor phosphorylation: effects of okadaic acid. | 2000-02 |
|
| Studies on the mechanism of fibrate-inhibited expression of plasminogen activator inhibitor-1 in cultured hepatocytes from cynomolgus monkey. | 1997-01 |
Patents
Sample Use Guides
MLP−/− Mice were treated with Ro 31-8220 at dose 6 mg/kg/d, s.c.
Route of Administration:
Other
To compare the effect of PKC inhibition or downregulation on neuritogenesis, at 24 h after plating, the neuroblastoma x •glioma NG108-15 hybrid cells were placed in serum free high-glucose DMEM supplemented with 0.015% dimethyl sulfoxide (DMSO) (control) or 1 mkm Go6983 plus 1 mkm Ro318220 to inhibit PKCs or with 300 nm PMA to downregulate PKCs, and morphological changes were examined after 24 or 48 h.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 17:37:44 GMT 2025
by
admin
on
Wed Apr 02 17:37:44 GMT 2025
|
| Record UNII |
3JPC9J3C82
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00896763
Created by
admin on Wed Apr 02 17:37:44 GMT 2025 , Edited by admin on Wed Apr 02 17:37:44 GMT 2025
|
PRIMARY | |||
|
11628205
Created by
admin on Wed Apr 02 17:37:44 GMT 2025 , Edited by admin on Wed Apr 02 17:37:44 GMT 2025
|
PRIMARY | |||
|
138489-18-6
Created by
admin on Wed Apr 02 17:37:44 GMT 2025 , Edited by admin on Wed Apr 02 17:37:44 GMT 2025
|
PRIMARY | |||
|
3JPC9J3C82
Created by
admin on Wed Apr 02 17:37:44 GMT 2025 , Edited by admin on Wed Apr 02 17:37:44 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
IC50
|
||
|
PARENT -> SALT/SOLVATE |
|
